Novartis
ILARIS
Manufacturer:
Novartis
Name:
ILARIS
HCPCS Code Descriptor:
Injection, canakinumab, 1 mg
Category:
J Code
HCPCS:
J0638
NDC(s):
00078-0734-61
Primary Type:
Immunology:Anti-TNF
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
ILARIS is an Immunology:Anti-TNF drug manufactured by Novartis and administered via the Subcutaneous route of administration. The J Code: J0638 is aligned to the drug ILARIS.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/11
HCPCS Effective Date:
1/1/11
HCPCS Short Description:
Canakinumab injection
Billing and Coding Guide:
https://www.ilarishcp.com/assets/pdfs/Ilaris_PFS_PA_Appeals_Kit.pdf
Patient Assistance:
https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment